Navigation Links
Baby Quasar announces the launch of its next-gen skin care tool, Clear Rayz, for the treatment of acne
Date:11/26/2012

SARASOTA, Fla., Nov. 26, 2012 /PRNewswire/ -- The Clear Rayz represents a dramatic advance in acne care. Using both red and blue therapeutic light, the Clear Rayz helps to treat mild to moderate inflammatory acne. The treatment has none of the side effects that plague so many acne medications or topical products. It works on all skin types and ages from teen to adult.

(Photo: http://photos.prnewswire.com/prnh/20121126/FL17758-a)
(Photo: http://photos.prnewswire.com/prnh/20121126/FL17758-b)

Acne is the most common skin disorder. It affects most people at some point in their lives and has a significant impact on self-esteem. Current estimates suggest that consumers spend more than $250 million each year on acne treatments in the U.S. alone.

The Clear Rayz utilizes a patented double sided design that provides acne patients with the maximum light power to achieve the best results. The blue light kills the acne bacteria on the skin. The red light stimulates circulation, healing, and reduces inflammation commonly associated with acne breakouts. It is this combination of benefits that makes the Clear Rayz so unique.

Clear Rayz is classified as a Class II medical device and is cleared for treating mild to moderate inflammatory acne. Clear Rayz utilizes natural, safe, painless, high spectral purity light wavelengths, which are 415 and 660 nanometers. There are no harmful UV rays or irritating chemicals.  

About Quasar Bio-Tech Inc.
In 2007, Quasar Bio-Tech redefined skin care and put professional tools in the hands of consumers by introducing revolutionary new home use medical technology, the Baby Quasar. As an industry leader in premium consumer skin care tools, Quasar Bio-Tech continues its commitment to bring the highest quality professional type devices to the market through ongoing research and development. All Quasar Bio-Tech products are made in the USA.

 

 

 


'/>"/>
SOURCE Quasar Bio-Tech Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Calif. and KANSAS CITY, ... Children,s Hospitals Neonatal Consortium (CHNC) has selected Velos ... their visionary data management and multicenter initiatives. ... organization comprised of 32 Neonatal Intensive Care Units ... America . The consortium provides a benchmark ...
(Date:1/17/2017)... , Jan. 17, 2016  Attorney Advertising -- Bronstein, Gewirtz ... purchasers of Anthera Pharmaceuticals, Inc. ("Anthera" or the "Company") (NASDAQ: ... additional information and assist the investigation by visiting the firm,s ... Anthera and certain of its officers and/or directors have violated ... 1934. ...
(Date:1/17/2017)...   Tocagen Inc ., a clinical-stage, cancer-selective gene therapy company, ... research and pharmaceutical development at Tocagen, will present at Phacilitate ... 17-20 in Miami . Details ... ... replicating viruses - what to do when and why Date and ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... January 17, 2017 , ... ... companies and ranked among the top US security companies for consecutive years, today ... This announcement brings a year-long independent board nomination process to a close and ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... Center and the Montclair State University’s Athletic Training Education program forged a relationship ... Athletic Training Education Program, which is consists of both student members and ...
(Date:1/16/2017)... ... ... California Southern University has named Dr. Steven Beazley University President. ... a core faculty member, teaching master’s and doctoral courses in the university’s School of ... where he earned his Doctor of Psychology degree in 1998. Dr. Beazley also has ...
(Date:1/16/2017)... ... January 16, 2017 , ... With the Grand Opening Event planned for ... use by sports teams and the general public. Built in five months by Centerpoint, ... be converted into basketball or pickleball courts. The space is also suitable for indoor ...
(Date:1/16/2017)... ... January 16, 2017 , ... As New York’s ... Victor Giamos, MD to their medical staff, according to eye surgeon, Jeffrey Martin, ... Eye Care, a division of SightMD. Dr. Giamos will practice primarily out of ...
Breaking Medicine News(10 mins):